创模生物科技(北京)有限公司

CN / En

NEWS

Advantages of the 3D Organoid Platform of InnoModels Biotechnology

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-09-19 16:12
  • Views:

(Summary description)As a leader in the life science field, InnoModels Biotechnology (Beijing) Co., Ltd. has always been committed to promoting technological innovation and providing scientists with advanced experimental tools. Among them, the 3D organoid platform of InnoModels Biotechnology opens up a new dimension for cell research and drug development, and shows significant advantages.

Advantages of the 3D Organoid Platform of InnoModels Biotechnology

(Summary description)As a leader in the life science field, InnoModels Biotechnology (Beijing) Co., Ltd. has always been committed to promoting technological innovation and providing scientists with advanced experimental tools. Among them, the 3D organoid platform of InnoModels Biotechnology opens up a new dimension for cell research and drug development, and shows significant advantages.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-09-19 16:12
  • Views:
Information

As a leader in the life science field, InnoModels Biotechnology (Beijing) Co., Ltd. has always been committed to promoting technological innovation and providing scientists with advanced experimental tools. Among them, the 3D organoid platform of InnoModels Biotechnology opens up a new dimension for cell research and drug development, and shows significant advantages.
1. Highly reproducible biological environment
The core advantage of 3D organoid platform is that it can highly reproduce the real biological environment. This platform simulates the microenvironment of human organs by culturing cells in vitro and making them self-organize to form a three-dimensional structure. Compared with traditional 2D cell culture technology, the 3D organoid platform can better simulate the complex structure and physiological functions of organs, thus providing more reliable research models. For example, it can simulate the structure and function of complex organs such as liver, heart, lungs, etc., making the research results closer to the real situation in the body.
2、Support self-assembly of multiple cell types
The 3D organoid platform of InnoModels Biotechnology supports the self-assembly of multiple cell types, which means it can simulate more complex biological systems. This capability provides a wide range of application possibilities for research in different fields, from basic cell biology to disease modeling and drug development, all of which can be more deeply researched with the help of this platform. Scientists can choose a combination of different cell types according to specific research needs in order to construct an in vitro model that is closest to the target organ.

 


3. Accelerate drug screening and evaluation
The 3D organoid platform not only provides a highly reductive biological environment, but also supports high-throughput experiments, thus significantly accelerating the drug screening and evaluation process. This platform can rapidly assess the toxicity and efficacy of potential drugs or compounds, providing valuable experimental data for drug development. In the early stages of drug development, drug screening through the 3D organoid platform can significantly reduce the cost and risk of drug development and improve the success rate of drug development.
4、Customized Experimental Solutions
InnoModels Biotechnology provides customers with customized experimental solutions, making technical adjustments according to the special needs of the research project. This personalized service ensures that scientists have access to data that best meets their research goals. Whether they need to simulate the microenvironment of a specific disease or evaluate the efficacy of a specific drug, the 3D organoid platform of InnoModels Biotechnology is able to provide precise experimental design and analysis of results.
5. Wide range of applications
The 3D organoid platform of InnoModels Biotechnology has demonstrated its wide application value in many fields. In the field of drug research and development, it can be used for pre-screening and evaluation of drugs to accelerate the process of drug research and development; in the field of disease research, by simulating the micro-environment of a specific disease, a more realistic disease model is established, which is helpful for in-depth study of the disease mechanism; in the field of individualized medical treatment, by providing a research platform that is closer to the real physiological environment, it is possible to provide personalized treatment plans for patients.
Conclusion
To summarize, 3D organoid platform of InnoModels Biotechnology has demonstrated significant advantages in the field of life science. By highly restoring the biological environment, supporting self-assembly of multiple cell types, accelerating drug screening and evaluation, providing customized experimental solutions, and a wide range of application areas, this platform is gradually becoming an important tool for advancing biomedical research and drug development. With the continuous advancement of technology and the expansion of applications, it is believed that the 3D organoid platform of InnoModels Biotechnology will play an even more important role in the future and make greater contributions to the development of life sciences.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司